drugset / Trial / NCT00530101

The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

NCT00530101 ↗

Phase 1 Completed 3 enrolled University of Miami Mallinckrodt · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to evaluate MR imaging in subjects receiving doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA scans. This research study is expected to enroll approximately 10 subjects over 12 months at the University of Miami / Miller School of Medicine.

Timeline

Start
2004-07
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxorubicin Other / unclassified — —

Indications